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Abstract 
Background: The evidence base for behavioural activation (BA) is mainly grounded in the 
individual delivery method, with much less known about the impact of group delivery.   
Aims: To conduct a pilot study of behavioural activation in groups (BAG) for depression 
delivered in a routine service setting, in order to explore acceptability, effectiveness and 
predictors of outcome.  Methods: The manualised group treatment format was delivered in a 
primary care mental health setting; at step three of an Improving Access to Psychological 
Therapies (IAPT) service.  BAG was facilitated by cognitive-behavioural psychotherapists 
and outcome measures (depression, anxiety and functional impairment) were taken at each 
session.  Seventy-three participants were referred and treated within nine groups.  Results:  
BAG was an acceptable treatment generating a low dropout rate (6.9%).  Significant pre-post 
differences were found across all measures.  There was a moderate to large depression effect 
size (d+ = 0.74), and 19.7% met the criteria for a reliable recovery in depression.  Greater 
severity of initial depression and attendance of at least four BAG sessions predicted better 
outcomes.   Conclusions: BAG appears an effective depression treatment option that shows 
some clinical promise.  Further larger and more controlled studies are nevertheless required. 
 
Key words: depression; behavioural activation; group therapy; pilot; clinical effectiveness; 
IAPT 
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Effectiveness of Group Behavioural Activation for Depression: A Pilot Study 
What people do (i.e. their behaviour) and its function (i.e. the short and long-term 
consequences of actions) plays a key-maintaining role in depression (Curran, Ekers, 
McMillan, & Houghton, 2012)-DFREVRQHWDO¶VODQGPDUNFRPSRQHQWDQDO\VLVRIWKH
treatment of depression found that behavioural activation (BA) had equivalent outcomes to 
cognitive behavioural therapy (CBT) at both treatment termination and 6-month follow-up.  
This study reignited clinical interest in behaviour therapy as a stand-alone treatment for 
depression (Martell, Addis, & Jacobson, 2001).  Subsequent studies and meta-analyses have 
consistently demonstrated BA to be a clinically effective stand-alone treatment (Cuijpers, van 
Straten, & Warmerdam, 2007; Dimidjian & Davis, 2009; Ekers et al., 2014; Mazzucchelli, 
Kane, & Rees, 2009).  Consequently, BA has been delivered in both low and high intensity 
versions as part of the Improving Access to Psychological Therapies (IAPT) services in 
England (Clark, 2011).  
However, when updating the clinical guidelines for depression, the National Institute 
for Health and Clinical Excellence (NICE) stated that the BA evidence base was not yet 
compelling and called for more studies to be conducted (NICE, 2009).  The Richards et al. 
(2016) recent large (N=221) non-inferiority trial provided robust evidence of individual BA 
being no less effective than CBT.  As the rates of infrequent adverse incidents were also 
equally distributed between the arms%$ZDVSURPRWHGDVDSRWHQWLDOµIURQWOLQH¶GHSUHVVLRQ
intervention.  In public services, increasing and amplified demand for psychological 
treatments and the need for organisationally efficient systems within restricted funding 
arrangements means that group delivery of treatments is often an attractive option (Kellett, 
Clarke, & Matthews, 2007). There is still debate, however, as to whether group delivery is as 
effective as individual delivery for depression (Cuijpers, van Straten, & Warmerdam, 2008), 
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as any small initial increased effects of individual over group CBT appear to diminish at 
follow-up (Huntley, Araya, & Salisbury, 2012). 
BA is advocated is adaptable to a group delivery method because of its parsimonious 
and teachable behavioural principles are relatively easy for facilitators to disseminate to 
clients (Jacobson et al., 1996; Richards et al., 2016; Sturmey, 2009).  However, in 
comparison to individual BA, much less is known about the impact of BA delivered in a 
group format.  The extant literature regarding group delivery of BA is based largely in 
clinical specialities or co-morbid populations, such as drug users undergoing inpatient 
substance abuse treatment (Daughters et al., 2008), patients with severe obesity (Alfonsson, 
Parling, & Ghaderi, 2015), young adolescents (Chu, Colognori, Weissman, & Bannon, 2009), 
opioid replacement therapy (Ross et al., 2012), and combat veterans in an inpatient PTSD 
unit (Wright, 2002).  The feasibility and effectiveness of group delivery of BA in more 
mainstream clinical services has been less well researched.  Porter, Spates and Smitham 
(2004) piloted a ten-session group BA intervention (N = 37 patients) in primary care, 
UHVXOWLQJLQVLJQLILFDQWO\UHGXFHGGHSUHVVLRQ+RXJKWRQ&XUUDQDQG6D[RQ¶V(2008) 
uncontrolled evaluation of five treatment groups (N = 42 patients) in secondary care found 
that ten-sessions of behavioural activation in groups (BAG) was an effective treatment, with 
a low drop-out rate.   
When delivering treatments in routine service settings, an important consideration is 
the potential role of co-morbidity. In Primary Care services, rates of co-morbidity between 
anxiety and depression are typically high (Löwe et al., 2008; Zbozinek et al., 2012).  
,QWHUYHQWLRQHIIHFWLYHQHVVLQ,$37LVGHILQHGE\³change in a person, rather than just a 
syndrome´,$37SDQGWKHUHIRUHUHOLDEle recovery is defined by the co-
consideration of both anxiety and depression outcomes.  As behavioural activation was 
originally designed as an intervention for low mood (Martell, Addis & Jacobson, 2001), its 
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impact on co-morbid symptoms of anxiety was not considered in the initial group delivery 
studies (Porter et al., 2004; Houghton et al., 2008).  Therefore, the impact that BAG has on 
anxiety across different clinical populations also needs to be examined in order to support its 
position as an evidence-based treatment option (NICE, 2009).  
The purpose of the current study was to contribute to the BAG evidence base by 
conducting a pilot study of the implementation of BAG within a routine Primary Care mental 
health service containing two samples (depressed students and depressed routine referrals).  
The aims of the study were to (1) index clinical characteristics of patients accessing BAG and 
associated dropout and treatment completion rates, (2) define the clinical effectiveness of 
BAG both at a group level in terms of effect sizes and at an individual level in terms of 
applying robust outcome recovery metrics (IAPT, 2014) and (3) identify potential predictors 
of outcomes.  Specific study hypotheses were as follows; (1) that significant reductions in 
depression and anxiety would occur during BAG, (2) that reductions in depression and 
anxiety would occur regardless of initial depression severity and (3) outcomes would be 
equivalent regardless of clinical population (across sub-samples). Due to the relative scarcity 
of evidence for group delivery of BA in comparison to individual BA (Ekers et al., 2014), the 
design of this pilot study is consistent with research carried out within the first stage of the 
Salkovskis (1995) hourglass model of intervention evaluation.     
 
Method 
Participants    
A total of 73 participants were initially referred to BAG. There were two sub-samples ± (1) 
students seen in a University counselling centre (N=46; 4 groups delivered in the student 
counselling centre) and (2) mainstream IAPT service users (N=27; 5 groups delivered in GP 
[general practitioner/family physician] practices).  All participants had a primary presenting 
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problem of depressive symptoms initially identified by a GP and then verified by a clinical 
assessment at initial screening by psychological wellbeing practitioners (PWPs) in the IAPT 
service or by staff in the student counselling centre.  Self-referral to BAG was not available. 
The sample was representative of typical referrals within routine practice and therefore not all 
participants UHIHUUHGWR%$*PHWµFDVHQHVV¶IRUGHSUHVVLRQVFRUHGDERYHWKHFOLQLFDOFXW-off 
pre-treatment). The nine groups ranged in size from 5-11, with an average group size of 8.11 
(SD = 1.90).  The authors assert that all procedures contributing to this work comply with the 
ethical standards of NHS research (IRAS ref: 52311) on human experimentation and with the 
Helsinki Declaration of 1975, and its most recent revision. 
  
Treatment  
BAG was delivered via a manualised treatment protocol by a total of eight British 
Association for Behavioural and Cognitive Psychotherapies (BABCP) accredited CBT 
psychotherapists. BAG was conducted as part of the step 3 IAPT µKLJKLQWHQVLW\¶service 
provision.  The treatment manual was adapted for primary care and based on the Houghton et 
al. (2008) protocol.  All BAG facilitators attended a facilitator training induction meeting 
concerning group delivery of BA and were already familiar with delivering individual BA 
within their role as CBT psychotherapists. Two therapists facilitated each group. Novice 
facilitators were paired with an experienced group facilitator, who delivered the session 
content. The role of the novice facilitator in groups was to review the previous session and 
between-session work. The same experienced facilitators led the treatment delivery across 
both clinical sub-samples, but were paired with different novice facilitators in order to train 
up a pool of experienced facilitators. Treatment fidelity was monitored via (a) co-facilitator 
debriefing following each session and (b) facilitator supervision following each group course. 
Eight weekly two-hour sessions of BAG were delivered for the non-student sample and seven 
weekly two-hour sessions for the student sample (this difference was in order to fit within 
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term time). Participants were provided with a welcome pack in the post and then a treatment 
workbook at the first group session.  Each group session topic focus was aligned to relevant 
BA treatment principles (see Table 1).  Treatment content was grounded within the following 
core theoretical principles (a) mood-activity linkage, (b) a behavioural µRXWVLGHLQ¶approach 
to change, (c) the importance of values-driven and values-consistent behaviour, (d) increasing 
access to a wide variety of naturally occurring positive reinforcement, (e) reducing avoidance 
via TRAP and TRAC techniques and (f) rumination-cued action.   
________________________ 
Insert Table 1 about here 
________________________ 
 
Measures  
Participants completed the IAPT minimum dataset at the beginning of every BAG 
session.  The measures were as follows:     
Patient Health Questionnaire (PHQ-9) 
The PHQ-9 (Kroenke, Spitzer, & Williams, 2001; scored between 0-27) was the 
primary outcome measure.  The PHQ-9 was designed to detect depression within primary 
care settings, and items are derived from Diagnostic and Statistical Manual of Mental 
Disorders (4th ed.; DSM-IV; American Psychiatric Association, 2000) classifications 
pertaining to lowered mood and physiological changes. Sensitivity and specificity for the 
PHQ-9 have been identified at 92% and 80% respectively at the >10 cut off point (Gilbody, 
Richards, Brealey, & Hewitt, 2007). Depressive symptom severity was classified using the 
following PHQ-9 severity index scores defined by Kroenke et al. (2001); µminimal¶ (0-4), 
mild (5-9), µmoderate¶ (10-14), µmoderately severe¶ (15-19) and µsevere¶ (20-27).  
Generalised Anxiety Disorder Assessment (GAD-7) 
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The GAD-7 (Spitzer, Kroenke, Williams, & Lowe, 2006; scored between 0-21) is a 
severity measure of anxiety widely used in primary care. Applying a threshold score of 8 
affords 92% sensitivity and 76% specificity (Swinson, 2006).  Anxiety symptom severity was 
classified using the following GAD-7 severity index scores defined by Spitzer et al. (2006); 
µminimal¶ (0-4), µmild¶ (5-9), µmoderate¶ (11-14) and µsevere¶ (15-21).  
Work and Social Adjustment Scale (WSAS) 
The WSAS (Mundt, Marks, Shear, & Greist, 2002; scored between 0-40) offers a 
valid, reliable measure of disability in terms of functional impairment as a result of mental 
health problems, and has good internal consistency and test-retest reliability.  WSAS scores 
are sensitive to disorder severity and to treatment effects (Mundt et al., 2002). 
Data Analyses   
Aim 1: Index dropout/completion rates and clinical characteristics  
 The sample was contextualised by reporting caseness and severity at intake. 
Independent samples t-WHVWVDQG3HDUVRQ¶V&KLVTXDUHZHUHused to compare demographic, 
attendance and psychometric differences between the sub-samples at pre-treatment.  
Acceptability of BAG was indexed via session attendance and dropout rates.  
Aim 2: Define the group and individual level of clinical effectiveness of BAG 
Outcome analysis was conducted using an intention-to-treat (ITT) approach, 
including all patients who entered treatment (i.e. had intake scores). Due to the use of 
session-by-session outcome monitoring, last-observation-carried-forward (LOCF) imputation 
was used to compute post-treatment scores in cases of missing data. This is consistent with 
IAPT criteria, whereby all patients who attend at least one treatment session (two contacts 
overall including initial screening) are deemed to be µcases¶.   
Firstly, to examine effectiveness at a group level, the pre±post change scores for each 
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BAG sample and for each sub-sample (i.e. students versus standard). Paired-samples effect 
sizes, unweighted by sample size were calculated using the standard deviation (SD) of the 
change scores as the denominator, taking into account the pre-post score correlation (Morris 
& DeShon, 2002). Confidence intervals for the effect sizes were calculated using Hedges & 
2ONLQ¶VIRUPXOD(IIHFWVL]HVZHUHFODssified XVLQJ&RKHQ¶VG(Cohen, 1992), defining 
d+  DVD³VPDOO´HIIHFWG+  DVD³PHGLXP´HIIHFWDQGG+ = .80 aVD³ODUJH´HIIHFW. 
Graphing of sessional measures was used to illustrate the shape of change. Comparison of 
change scores between sub-samples and across BAG groups was achieved using analysis of 
covariance (ANCOVA), controlling for intake scores.   
Secondly, individual level effectiveness was examined using recovery rate analysis on 
the whole sample and the two sub-samples. Categorical outcomes were calculated for each 
participant on the PHQ-9 and the GAD-7 using the original and updated national IAPT 
metrics (IAPT, 2014) to allow comparison.  The following category definitions were used (a) 
moving to recovery counted participants above the clinical cut-off before and below 
following BAG.  A participants ZDVDµFDVH¶ZKHQWKH\VFRUHGDERYHWKHFOLQLFDl threshold on 
depression and/or anxiety before BAG (i.e. PHQ-VFRUHDWDVVHVVPHQWDQGRU*$'-
at assessment).  Moving to recovery occurred when the final outcome score was below the 
clinical threshold on depression and anxiety (i.e. PHQ-9 score <10 at termination and GAD-7 
<8 at termination); (b) reliable improvement required that any improvement in outcome 
scores pre and post BAG exceeded measurement error of the PHQ-9 and GAD-7 using 
reliable change index (RCI; Jacobson & Truax, 1991).  Reliable improvement was a 
UHGXFWLRQRISRLQWVRQWKH3+4-RUSRLQWVRQWKH*$'-7 (IAPT, 2014).  Conversely, 
reliable deterioration was an increase in scores exceeding measurement error; (c) reliable 
recovery required reliable improvement in the PHQ-9 or GAD-7, and that the case had to 
additionally move below the clinical threshold on both the PHQ-9 and the GAD-7 at the end 
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of BAG; (d) a stasis outcome was recorded when there was no movement to recovery and 
neither reliable improvement or deterioration; (e) a harm outcome was recorded when a 
patient had a pre-post reliable deterioration on either the PHQ-9 or GAD-7 and also moved 
from non-case to case following BAG.  The outcome categories of moving to recovery 
(original criteria), reliable improvement, reliable deterioration and reliable recovery (updated 
criteria) are standard IAPT terms (IAPT, 2014).  Stasis and harm outcome categories were 
created as additional outcome categories by the research team.  
Aim 3: Identify predictors of outcome 
Paired-samples t-tests were used to compare pre- and post-BAG depression scores, 
and correlations were used to test the role of initial depression severity in predicting pre-post 
reductions.  The BAG dose-effect relationship was investigated by calculating reliable 
recovery rates by number of sessions attended and comparing group outcomes across 
different levels of attendance.  
 
Results   
Aim 1: Patient demographics, acceptability of treatment and clinical characteristics 
Within the total sample (N = 73), the gender distribution was 43 females (59%) with 
an average age of 31.12 years (SD = 14.58), and 30 males (41%) with an average age of 
34.97 years (SD = 14.66).   The overall age range was 19-77 years.  The majority were White 
British in ethnic origin (N=57; 78%), and 13 (18%) patients were in receipt of state welfare 
benefits during BAG. The mean number of BAG sessions attended was 5.19 (SD = 1.85).  In 
terms of consistency of attendance, 34 participants (47%) attended all the group sessions or 
all the group sessions minus one. One participant (1%) dropped out prior to BAG 
commencing and four participants (6%) dropped out after the first session, resulting in a 
drop-out rate of 7%. Figure 1 summarises demographics and attendance rates for each sub-
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sample.  Student and mainstream participants did not differ in terms of initial depression 
(t(69) = 1.51, p = .14) or GAD-7 score (t(69) = 0.22, p = .83) or on subsequent number of 
sessions attended (t(71) = 0.81, p = .42).  There was a significant difference in terms of age 
(t(71) = 12.64, p < .001), but not gender (X2(1, N = 71) = 0.29, p = .59). Due to the one 
participant who dropped out prior to BAG commencing and also one participant not 
completing the initial measures before dropping out after session one, the following ITT 
analyses relate to data available from the remaining 71 participants. In terms of the severity 
of depression, the overall pre-BAG PHQ-9 score was 16.07 (SD = 5.36); in categorical terms, 
seven participants had µmild¶ depressive symptoms, 21 µmoderate¶ depressive symptoms, 21 
µmoderately severe¶ depressive symptoms and 22 µsevere¶ depressive symptoms.  Therefore, 
43/71 (61%) met criteria for either µmoderately severe¶ or µsevere¶ depressive symptoms, 
with 64/71 (90%) reaching caseness prior to BAG. There was also evidence of high co-
morbidity with anxiety (mean pre-treatment GAD-7 score = 12.42, SD = 4.99); 44 (62%) 
scored in the µmoderate¶ (11-15) or µsevere¶ (15-21) anxiety symptoms ranges, and 56/71 
patients (79%) met overall caseness for anxiety prior to BAG.  
________________________ 
Insert Figure 1 about here 
________________________ 
Aim 2: Effectiveness of BAG ± group and individual level analyses  
Table 2 reports overall pre (session 1) to post (session 7/8) means, t-tests and 
associated effect sizes.  On the primary outcome measure (PHQ-9), there was a statistically 
significant reduction in symptoms of depression.  Significant reductions were also apparent 
on the secondary outcome measures of anxiety (GAD-7) and functional impairment (WSAS).  
Moderate to large effect sizes across all the outcome measures were apparent, with the PHQ-
9 outcomes nearing a large effect size (Cohen, 1992). The session by session PHQ-9 scores 
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for the sub-samples are presented in Figure 2. Outcome comparisons between the sub-
samples (controlling for intake scores) shows no significant differences in terms of 
depression (F(1,68) = 0.58, p = .45), anxiety (F(1,68) = 1.92, p = .17), or functional 
impairment (F(1,68) = 0.23, p = .64). Comparisons between individual BAG groups 
(controlling for intake scores) also found no significant differences in terms of depression 
(F(8,61) = 0.60, p = .77), anxiety (F(8,61) = 0.97, p = .47) or functional impairment (F(2,61) 
= 1.52, p = .17).   
________________________ 
Insert Table 2 and Figure 2 about here 
________________________ 
 
 Table 3 reports the depression and anxiety individual recovery rate analysis for the 
entire and sub-samples.  On the primary outcome measure (PHQ-9), 22 participants made a 
reliable improvement, with 14 of those participants also meeting the additional criteria for 
reliable recovery (i.e., 20% showed clinical and reliable change). Thirty-seven participants 
had a depression stasis outcome following BAG. Change rates were comparable across BAG 
groups.  Reliable improvement rates (including reliable recovery participants) were also 
evenly distributed across the clinical samples; student participants (N = 15, 33%) and 
standard IAPT participants (N = 7, 28%).  Similar recovery rates were observed for anxiety, 
with 21% also showing clinical and reliable change on the GAD-7.  When applying IAPT 
recovery metrics using participants¶VFRUHVRQERWKPHDVXUHV5% showed some form of 
reliable improvement following BAG, and a further 18% showed reliable improvement as 
well as reaching non-caseness for both depression and anxiety. Overall 44% experienced a 
reliably significant benefit whilst attending BAG. 
 _______________________ 
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Insert Table 3 about here 
________________________ 
 
Aim 3: Predictors of outcome 
Initial depression severity 
Table 4 reports the rates of depressive symptom severity pre and post BAG. On 
completing BAG, there were almost half as many participants with µmoderate to severe¶ or 
µsevere¶ depressive symptoms on the PHQ-9 (N = 24, 34%).  The number of participants 
meeting caseness following BAG reduced to N = 45 (63%) on the PHQ-9 and N = 41 (58%) 
on the GAD-7.  Figure 3 illustrates mean depression outcomes pre and post BAG by initial 
depressive symptom severity, to show that reductions were observed across all depression 
severities. The pre-post reductions for moderate (t(20) = 2.79, p = .011), moderately severe 
(t(20) = 4.04, p = .001) and severe depressive symptoms (t(21) = 3.72, p = .001) were 
significant, whilst the mild depressive symptoms reduction was not significant (t(6) = .90, p = 
.403).  Further investigation of the relationship between initial depressive symptom severity 
and change scores found a non-significant, small positive correlation nearing significance 
(PHQ-9; r(69) = .22, p = .07. 
________________________ 
Insert Table 4 and Figure 3 about here 
________________________ 
 
Dose-effect  
Figure 4 illustrates the percentage of participants who experienced reliable recovery 
when grouped according to the number of consecutive BAG sessions attended.  The criteria 
for a reliable recovery were not met by any single participant who attended fewer than four 
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sessions. Recovery criteria tended to be achieved by those who attended a minimum of four 
sessions. The likelihood of reliable recovery increased according to number of BAG sessions 
attended.  
________________________ 
Insert Figure 4 about here 
________________________ 
 
Figure 5 shows change scores according to number of sessions attended, showing that 
those patients attending <4 sessions achieved less change. Comparisons of initial depression 
severity for those who attended 3 sessions or fewer (M = 16.22, SD = 1.80), 4-6 sessions (M 
= 16.56, SD = 0.86) or 7-8 sessions (M = 15.13, SD = 1.12) showed no significant differences 
on initial PHQ-9 scores (F(2, 68) = .53, p = 0.60). The effect on mean depression (PHQ-9) 
change of the number of sessions attended (0-3, 4-6 or 7-8) was significant (F(2, 68) = 3.83, 
p = .027). Those who attended fewer than four BAG sessions experienced significantly less 
change in depressive symptoms compared to those who attended four-six sessions (p < .05). 
Mean change according to attendance at 4-6 and 7-8 group sessions was not significantly 
different (p = .86). T-tests on the pre and post BAG scores according to number of sessions 
attended demonstrated that significant reductions in depression were found only for those 
who attended four or more sessions (4-6 sessions: t(38) = 5.26, p < .001 and 7-8 sessions: 
t(22) = 3.90, p = .001).  Participants who attended fewer than three sessions did not 
experience a significant pre-post reduction in depression (t(8) = 0.65, p = .54).  
________________________ 
Insert Figure 5 about here 
________________________ 
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Discussion  
The evidence base for BA is mainly built around individual delivery, with very few 
studies investigating group delivery.  This pilot study investigated the routine implementation 
of BAG in order to index acceptability, effectiveness and predictors of outcome. The results 
supported the hypothesis that significant reductions in depression and anxiety would occur 
during BAG regardless of clinical population or initial depression severity. BAG appears a 
feasible primary care treatment at step 3 of IAPT services, particularly due to the low patient 
attrition rate observed.  Indeed, the more sessions attended, the greater the likelihood of 
benefit.  This pilot found that therapists already using BA in their individual work can rapidly 
assimilate BA principles and practice into a group delivery setting.   BAG as a treatment 
option is a clinical innovation in terms of plurality of intervention offered in primary care and 
appears efficient in terms of therapist to patient ratios (Kellett et al., 2007).   
The depression outcomes mirror the Porter et al. (2004) and Houghton et al. (2008) 
BAG evidence, albeit demonstrated in a larger and more diverse sample and with a shorter 
course of group therapy.  A third of participants made reliable improvements, with one in five 
making reliable recovery during the group.  BAG appears a safe intervention for depression, 
as no single participant was harmed or reliably deteriorated during treatment. The overall 
depression effect size found (d+ = 0.74) is categorised as nearing a large effect size and is 
similar to the between-groups effect sizes reported in the Cuijpers et al. (2007), Mazzucchelli 
et al. (2009) and Ekers et al. (2014) meta-analyses of BA and also trials of individually 
delivered BA (Dimidjian et al., 2006; Hopko, Lejuez, LePage, Hopko, & McNeil, 2003).   It 
should be noted that as the pre-post score correlation was > .5, the within-sample effect size 
reported in this study will appear larger than a between-groups effect size.  Facilitator 
training in BAG was achieved through coupling experienced to novice facilitators, and so 
enabled the service to quickly acquire a pool of experienced facilitators.  No differences were 
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found between groups or sub-samples indicating consistency of delivery of the manualised 
treatment approach (Degadillo et al., 2016).   
The presence of co-morbid anxiety symptoms did not appear to hinder BAG 
depression outcome.  Indeed, BAG appears to be beneficial for co-morbid anxiety symptoms 
(even those reaching caseness), with significant reductions, recovery rates and effect sizes for 
anxiety that all but matched the depression outcomes. This supports %$*¶VVXLWDELOLW\DVDQ
effective intervention in a real world primary mental health care setting, and its 
appropriateness as a step 3 intervention in IAPT services.  Four participants experienced a 
reliable deterioration in anxiety during BAG.  The reason for this is not clear, but evidence 
suggests that a relatively small but nontrivial minority of patients do deteriorate during 
psychotherapy, with estimates ranging from 3-10% (Mohr, 1995; Strupp, Hadley, & Gomes-
Schwartz, 1977).  BAG might not be suitable for patients with higher levels of co-morbid 
anxiety, but an alternative possibility is that such patients might require further anxiety-
specific evidence-based treatment following BAG.  
The high uptake and low dropout rates mirror previous preliminary findings 
(Houghton et al., 2008; Porter et al., 2004), implying that BAG is well tolerated as an 
intervention. The dropout rate for BAG is lower than for individual interventions delivered in 
IAPT services (NEPHO, 2010; Richards & Borglin, 2011).  However, different studies have 
used various definitions of dropout and so there is a need for a universally accepted dropout 
classification to enable researchers to compare rates with true confidence (Oldham, Kellett, 
Miles & Sheeran, 2012).  What it is about BA that is engaging for depressed patients does 
need researching, but an µRXWVLGH-LQ¶DSSURDFK&XUUDQHWDODSSHDUVuseful and non-
shaming.  Ensuring low dropout rates is vital, as increased attendance at BAG was associated 
with improved outcome across all measures. Attendance at a minimum of four group sessions 
was required to achieve significant improvements and to have a chance of meeting recovery 
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criteria. The importance of treatment completion for outcome is well evidenced in individual 
work (Cahill et al., 2003).  BAG was effective across all the clinical threshold severities of 
depression and across both clinical sub-samples, although it is acknowledged that regression 
to the mean may have influenced the effect seen for more severely depressed patients.   
 The main study weakness was the lack of a control group and random allocation 
(Lilienfeld, 2007), prohibiting understanding whether it was BA itself or participation in a 
group of similarly depressed people that facilitated the recorded psychological outcomes 
(Yalom & Leszcz, 2005).  Similarly, the lack of follow-up means the durability of BAG is 
not yet known.  Any assumptions about increased organisational efficiency through 
implementing BAG need to be cautiously framed, as it is not known if stasis patients then 
return to services to seek further treatment. As with outcome study in a routine service setting 
there was loss of data over time, which limits confidence in the results (Ahern & Le Brocque, 
2005). The use of the same outcome measure for pre and post assessment and session-by-
session monitoring also has its own drawbacks, in both the likelihood of testing effects and 
isolating change inapplicable to other outcome measures (Wampold, 2015).  All outcome 
data were self-report and therefore subject to recognised validity issues, such as social 
desirability bias with regards to over or under-reporting sensitive information (Tourangeau & 
Yan, 2007).  Future studies would benefit from using more mixed methods, such as 
combining self-report and diagnostic interviews. Further studies should aim to investigate 
and specify the mechanisms and moderators of change during BAG. There are currently no 
validated competency measures of BAG. Therefore, treatment fidelity was not accurately 
assessed and this represents a further future research need.   
 Although no patients experienced a reliable deterioration in depression or harm 
RXWFRPHRYHUKDOIRIDOOSDUWLFLSDQWVH[SHULHQFHGDµVWDVLV¶RXWFRPH%$*clearly is not a 
panacea for all individuals with depression.  The importance of stasis as a depression 
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outcome needs further detailed empirical and theoretical attention.  Depression has a core 
feature of hopelessness, and not benefitting from an intervention (despite it being evidence-
based) might HQKDQFHµIDLOXUH¶VFKHPDLQGHSUHVVHGSDWLHQWV.  Stasis rates should not be 
overlooked by services and researchers. As the reasons for stasis outcomes are not clear, 
detailed qualitative and quantitative investigation of stasis outcomes in depression are 
warranted.  Understanding what creates treatment stasis provides many opportunities for 
redesign and retesting consistent with the Salkovskis (1995) hourglass model.  The 
considerable rate of stasis observed in this study and other IAPT outcome research (e.g. Chan 
& Adams, 2014; Firth, Barkham, Kellett & Saxon, 2015; Green, Barkham, Kellett & Saxon, 
2014) demands attention as to why an evidenced-based intervention makes little impression 
on a substantial proportion of patients.    
 In conclusion, this pilot study has shown that an innovation on the Behavioural 
Activation approach (i.e., a manualised brief group delivery format) shows clinical and 
organisational promise.  Clearly, the evidence base for the BAG is dwarfed by the traditional 
individual approach and much research work on a larger scale is therefore indicated.  Patients 
suitable for a behavioural approach might be offered the choice of group or individual BA 
and a patient-choice RCT would be useful to test this (Howard & Thornicroft, 2006).  
Helping people to understand their values and align their behaviour accordingly in order to 
improve their lives appears a potent and simple approach when treating depression (Curran et 
al., 2012)&RPSOHWLQJVXFKµRXWVLGH-LQ¶ZRUNLQDVXSSRUWLYHJURXSHQYLURQPHQWLQZKLFK
vicarious learning from others can also take place appears a useful avenue for future clinical 
treatment.  
 
Note: The authors have no conflict of interest with respect to this publication. 
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Table 1: BAG treatment content (patient wording) 
Session Content 
1 Learn your patterns and start to change them 
2 Getting out of TRAPs and back on TRAC  
3 Taking action: a problem solving approach 
4 Values: the guide to who we are 
5 Developing responses to thinking, worry and rumination 
6 Making changes one step at a time 
7 Freeing yourself from mood dependence* 
8 Building the relationships you want/tying it all together* 
* The final two sessions were amalgamated into one session for the student sample.  
Note: TRAP = Trigger, Response, Avoidance Pattern; TRAC = Trigger, Response, 
Alternative Coping. 
 
 
 
 
 
 
 
  
 
Behavioural activation in groups 
 26 
Figure 1; demographics, severity and uptake of BAG by sub-sample 
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Table 2; BAG outcomes for the total sample and sub-samples  
Measures Pre-Mean 
(SD) 
Post-Mean 
(SD) 
Mean Change 
(SD) 
t-score Correlation 
between 
means 
d-value 95% 
confidence 
intervals 
Total (N=71)        
 
PHQ-9 16.07 (5.36) 12.59 (6.38) 3.48 (4.82) 6.08*** 0.68 0.74 0.40 ± 1.08 
 
GAD-7 12.42 (4.99) 9.56 (5.39) 2.86 (4.34) 5.55*** 0.65 0.66 0.32 ± 1.00 
 
WSAS 21.34 (6.72) 17.21 (8.56) 4.13 (6.57) 5.30*** 0.66 0.66 0.32 ± 1.00 
Student Patients (N=46)        
 
PHQ-9 15.37 (4.86) 11.72 (5.68) 3.65 (5.00) 4.96*** 0.56 0.74 0.32 ± 1.16 
 
GAD-7 12.33 (4.85) 9.00 (5.01) 3.33 (4.42) 5.12*** 0.60 0.75 0.33 ± 1.17 
 
WSAS 21.96 (4.84) 17.46 (8.29) 4.50 (6.57) 4.64*** 0.61 0.78 0.36 ± 1.20 
Non-student patients 
(N=25) 
       
 
PHQ-9 17.36 (6.06) 14.20 (7.35) 3.16 (4.55) 3.47** 0.79 0.73 0.16 ± 1.30 
 
GAD-7 12.60 (5.33) 10.60 (5.99) 2.00 (4.15) 2.41* 0.74 0.49 -0.07 ± 1.05 
 
WSAS 20.20 (9.25) 16.76 (9.19) 3.44 (6.63) 2.59* 0.74 0.52 -0.04 ± 1.08 
 
*p<0.05  **p<0.01  ***p<0.001  
Note: d-value  &RKHQ¶Vd effect size (0.2 = small, 0.5 = moderate, 0.8 = large) 
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Figure 2; session by session outcomes on the PHQ-9  
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Table 3: Recovery rate analysis for depression and anxiety during BAG 
 Depression  
(PHQ-9) 
Anxiety  
(GAD-7) 
IAPT Outcomes 
Anxiety & 
Depression 
 N (%) N (%) n (%) 
Total  (N=71)       
 Harm  0 (0) 0 (0) 0 (0) 
 Reliable deterioration*  0 (0) 4 (5.63) 4 (5.63) 
 Stasis  37 (52.11) 27 (38.03) 33 (46.48) 
 Moving to recovery** 20 (28.17) 18 (25.35) 16 (22.54) 
 Reliable improvement*  8 (11.27) 10 (14.09) 18 (25.35) 
 Reliable recovery* 14 (19.72) 15 (21.13) 13 (18.31) 
Student patients (N=46)      
 Harm  0 (0) 0 (0) 0 (0) 
 Reliable deterioration*  0 (0) 2 (4.35) 2 (4.35) 
 Stasis  23 (50.00) 17 (39.96) 21 (45.65) 
 Moving to recovery** 14 (30.44) 13 (28.26) 13 (28.26) 
 Reliable improvement*  5 (10.87) 6 (13.04) 11 (23.91) 
 Reliable recovery*  10 (21.74) 11 (23.91) 11 (23.91) 
Non-student patients (N=25)      
 Harm  0 (0) 0 (0) 0 (0) 
 Reliable deterioration*  0 (0) 2 (8.00) 2 (8.00) 
 Stasis  14 (56.00) 10 (40.00) 12 (48.00) 
 Moving to recovery** 6 (24.00) 5 (20.00) 3 (12.00) 
 Reliable improvement*  3 (12.00) 4 (16.00) 7 (28.00) 
 Reliable recovery*  4 (16.00) 4 (16.00) 2 (8.00) 
*Updated IAPT recovery criteria 
**Original IAPT recovery criteria  
Note: Original and updated IAPT recovery rate categories are not distinct and therefore not mutually 
exclusive; patients can be classified in both. Therefore, the N can total > 100% 
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Table 4: Pre and post depressive symptom severity rates  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depressive symptom 
severity 
Pre Post 
n  (%) N (%) 
Minimal (0-4) 1 (1.38) 5 (6.94) 
Mild (5-9) 7 (9.72) 21 (29.17) 
Moderate (10-14) 21 (29.17) 21 (29.17) 
Moderately severe (15-19) 21 (29.17) 12 (16.67) 
Severe (20-27) 22 (30.56) 13 (18.06) 
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Figure 3: PHQ-9 outcomes pre and post BAG according to initial depressive symptom 
severity  
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Figure 4; rate of reliable recovery by number of BAG sessions attended   
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Figure 5; Mean outcome change according to number of BAG sessions attended 
 
 
 
 
 
 
 
 
 
 
-2
-1
0
1
2
3
4
5
6
7
PHQ-9 GAD-7 WSAS
M
ea
n
 c
ha
n
ge
 in
 o
u
tc
o
m
e 
sc
o
re
 
Outcome measures 
0-3 sessions (N=9)
4-6 sessions (N=39)
7-8 sessions (N=23)
